Table 1 Baseline patient characteristics

Women

19 (29%)

8 (40.0%)

Age (years)

67 ± 9^†

62 ± 11

BSA (m²)

2.0 ± 0.2^†

1.9 ± 0.2

Diabetes

9 (14%)

0

QRS-duration (ms)

167 ± 17^†††

95 ± 11

LBBB

56 (86%)

N/A

Heart rate (beats/min)

67 ± 13^†

62 ± 7

NIBP (mmHg)

 Systolic

127 ± 17

131 ± 13

 Diastolic

76 ± 9

75 ± 7

Medication

0

 ACEI/ARB

65 (100%)

 Betablocker

58 (89%)

 Diuretics

56 (86%)

 Antihyperlipidemics

41 (63%)

 Platelet aggregation inhibitors

35 (54%)

NYHA Class

N/A

 NYHA Class II

20 (31%)

 NYHA Class III

41 (63%)

 NYHA Class IV

4 (6%)

Etiology

 Ischemic

32 (49%)

 Non-ischemic

33 (51%)

LVEDV (ml)

326 ± 115^†††

163 ± 37

LVESV (ml)

246 ± 110^†††

66 ± 21

LVSV (ml)

80 ± 23^††

97 ± 20

LVEF (%)

26 ± 8^†††

60 ± 5

LV mass (g)

170 ± 49^†††

112 ± 32

CO (l/min)

5.3 ± 1.5^†

6.0 ± 1.2

LVAVPD (mm)

8.3 ± 3.2^†††

15.3 ± 1.6

SA area (cm²)

51 ± 11^†††

34 ± 7

SV_long% (%)

53 ± 18^††

64 ± 8

SV_lat% (%)

41 ± 16^†††

29 ± 7

SV_sept% (%)

0 ± 15^†††

10 ± 4

LGE positive

40 (62%)

N/A